论文部分内容阅读
目的:观察低分子肝素钙治疗慢性肺源性心脏病(肺心病)的疗效及安全性。方法:78例肺心病患者随机分为两组,对照组38例给予常规综合治疗,治疗组40例在常规综合治疗的基础上加用低分子肝素钙5 000 U,2次/d,皮下注射,疗程7 d。结果:治疗组的有效率高于对照组,提高氧分压,降低二氧化碳分压均优于对照组。结论:低分子肝索钙治疗肺心病安全有效。
Objective: To observe the efficacy and safety of low molecular weight heparin in the treatment of chronic cor pulmonale (pulmonary heart disease). Methods: Seventy-eight patients with cor pulmonale were randomly divided into two groups. The control group of 38 patients were given conventional therapy. Forty patients in the treatment group were treated with low-molecular-weight heparin calcium (5 000 U, twice daily, subcutaneous injection) on the basis of conventional comprehensive therapy , Treatment 7 d. Results: The effective rate of the treatment group was higher than that of the control group. Both the oxygen partial pressure and the partial pressure of carbon dioxide were better than the control group. Conclusion: Low molecular weight hepatic calcification for pulmonary heart disease is safe and effective.